News on veterinary diagnostics and testing.
The company recently signed on Heska for selling its Nu.Q Vet Cancer Screening Test at the point of care, and Sage Healthcare as a distributor in Singapore.
In a recent study, company researchers and their collaborators found that tumors in dogs and humans share mutational hotspots in a number of cancer-related genes.
PetDx Raises $62M in Series B Round
The company plans to use the new funding in part to accelerate the rollout of its flagship OncoK9 liquid biopsy assay for detecting cancer in dogs.
The firm's panel test, which will initially cost $400, identifies genetic biomarkers linked to over 20 cancers in dogs using cell-free and genomic DNA from blood.
Boehringer Ingelheim, GNA Biosolutions Partner on African Swine Fever Dx
The firms are focusing on developing a rapid diagnostic test for African swine fever that can be used on GNA's portable MDx platform.